CURRICULUM VITAE - Stanford University School of Medicine
CURRICULUM VITAE - Stanford University School of Medicine
CURRICULUM VITAE - Stanford University School of Medicine
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Phenotype. Journal <strong>of</strong> Infectious Diseases, 174: 854-57, 1996.<br />
55. Goulston C, Stevens E, Gallo D, Mullins J, Hansen C, and Katzenstein DA. Human<br />
Immunodeficiency Virus in Plasma and Genital Secretions during the menstrual cycle.<br />
Journal <strong>of</strong> Infectious Diseases, 174: 858-61, 1996.<br />
56. Hammer SM, Katzenstein DA, Hughes M, Gundacker H, Blaschke T, <strong>School</strong>ey RT,<br />
Simpson D, Haubrich R, Henry WK, Lederman M, Phair JP, McLaren C, Rooney J,<br />
Salgo M, Nui M, Hirsch MS, and Merigan TC. Nucleoside monotherapy vs.Combination<br />
therapy in HIV infected adults: A randomized, double blind, placebo controlled trial in<br />
persons with CD4 cell counts between 200 and 500 per cubic millimeter. New England<br />
Journal <strong>of</strong> <strong>Medicine</strong>, 335(15) : 1081-90, 1996.<br />
57. Katzenstein DA, Hammer SM, Hughes M, Gundacker H, Jackson B, Fiscus S, Lathey<br />
J, Rasheed S, Elbeik T, Reichman R, Japour A, Scott W, Griffiths B, Winters M,<br />
Merigan TC, and Hirsch M. Virologic and Immunologic Markers and Clinical Outcomes<br />
After Nucleoside Therapy in Adults With 200 to 500 CD4 Cells Per Cubic Millimeter.<br />
NIAID Sponsored AIDS Clinical Trials Group Study 175, A Virology Substudy. New<br />
England Journal <strong>of</strong> <strong>Medicine</strong>, 335: 1091-98, 1996.<br />
58. Basset M, Ray S, Mbizvo M, Machekano R, van de Wijgert J, McFarland W, Katzenstein<br />
DA. Risk factors for HIV infection at enrollment in an urban male factory cohort in<br />
Harare, Zimbabwe. Journal <strong>of</strong> Acquired Immune Deficiency Syndromes and<br />
Retrovirology, 13: 287-93, 1996.<br />
59. Mbizvo M, Ray S, Machekano R, Latif W, McFarland W, Katzenstein DA. HIV<br />
seroincidence and behavioral correlates <strong>of</strong> seroconversion in a cohort <strong>of</strong> male factory<br />
workers in Harare, Zimbabwe. AIDS; 10: 895-901, 1996.<br />
60. Mason PR, Gwanzura L, Latif A, Ray S, van de Wijgert J, Katzenstein DA. Antimicrobial<br />
susceptibility patterns amongst group B streptococci from women in Harare, Zimbabwe.<br />
International Journal <strong>of</strong> Antimicrobial Agents ( in press, 1996).<br />
61. Ray S, Mason PR, Smith H, Rogers L, Tobaiwa O, Katzenstein DA. An evaluation <strong>of</strong> dipstick<br />
ELISA in the detection <strong>of</strong> antibodies to HIV-1 and 2 in Zimbabawe. Tropical<br />
<strong>Medicine</strong> and International Health, 2(1): 83-88, 1997.<br />
62. Yen-Lieberman B, Brambila D, Jackson B, Bremer J, Coombs R, Cronin M, Katzenstein<br />
D, Leung S, Lin P, Palumbo P, Rasheed S, Todd J, Vahey M, Reichelderfer P.<br />
Preliominary evaluation <strong>of</strong> a quality assurance program (QAP) for detection <strong>of</strong> Human<br />
Immunodeficiency Virus type 1 plasma RNA by the AIDS Clinical Trials Group. Journal<br />
<strong>of</strong> Clinical Microbiology 43: 2695-270, 1996;<br />
63. David Katzenstein. Antiretroviral Therapy for Human Immunodeficiency Virus Infection<br />
in 1997. Western Journal <strong>of</strong> <strong>Medicine</strong>, 166: 319-325, 1997.<br />
64. Carpenter CCJ, Fischl M, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA,<br />
Montaner J, Richman DD, Saag MS, <strong>School</strong>ey RT, Thompson MA, Vella S, Yeni PG,<br />
and Volberding PA. Antiretroviral Therapy for HIV Infection in 1997: Updated<br />
Recommendations <strong>of</strong> an International AIDS Society - USA Panel. Journal <strong>of</strong> the<br />
American Medical Association, 277: 1962-69, 1997.<br />
9
Change language